| Synthesis of new polycyclic oxazol-2-one derivatives by a tandem [4+ 2] cycloaddition/cyclopentannulation/1, 5-sigmatropic rearrangement process of Fischer (arylalkynyl)(alkoxy … L Reyes, H Mendoza, MA Vázquez, F Ortega-Jiménez, A Fuentes-Benítes, ... Organometallics 27 (17), 4334-4345, 2008 | 18 | 2008 |
| Synthesis of acyldodecaheterocycles derived from (1R)-(–)-myrtenal and evaluation as chiral auxiliaries ME Vargas-Díaz, HL Mendoza-Figueroa, MJ Fragoso-Vázquez, ... Tetrahedron: Asymmetry 23 (22-23), 1588-1595, 2012 | 11 | 2012 |
| Synthesis, antimicrobial activity, and molecular docking study of fluorine-substituted indole-based imidazolines HL Mendoza-Figueroa, MT Serrano-Alva, G Aparicio-Ozores, ... Medicinal Chemistry Research 27, 1624-1633, 2018 | 10 | 2018 |
| Modifications on the tetrahydroquinoline scaffold targeting a phenylalanine cluster on GPER as antiproliferative compounds against renal, liver and pancreatic cancer cells D Méndez-Luna, LA Morelos-Garnica, JB García-Vázquez, M Bello, ... Pharmaceuticals 14 (1), 49, 2021 | 9 | 2021 |
| Highly regioselective enzymatic synthesis of lutein-3-monoesters JA Lujan-Montelongo, HL Mendoza-Figueroa, C Silva-Cuevas, ... Tetrahedron letters 59 (46), 4096-4101, 2018 | 9 | 2018 |
| Anti-epileptic activity, toxicity and teratogenicity in CD1 mice of a novel valproic acid arylamide derivative, N-(2-hydroxyphenyl)-2-propylpentanamide JM Cristóbal-Luna, J Correa-Basurto, HL Mendoza-Figueroa, ... Toxicology and Applied Pharmacology 399, 115033, 2020 | 7 | 2020 |
| Exploring the biotransformation of N-(2-hydroxyphenyl)-2-propylpentanamide (an aryl valproic acid derivative) by CYP2C11, using in silico predictions and in vitro studies JE Mendieta-Wejebe, A Silva-Trujillo, M Bello, HL Mendoza-Figueroa, ... Journal of Pharmacy and Pharmacology 72 (7), 938-955, 2020 | 7 | 2020 |
| In silico drug repositioning to target the SARS-CoV-2 main protease as covalent inhibitors employing a combined structure-based virtual screening strategy of pharmacophore … LH Vázquez-Mendoza, HL Mendoza-Figueroa, JB García-Vázquez, ... International Journal of Molecular Sciences 23 (7), 3987, 2022 | 6 | 2022 |
| Pharmacophore modeling and conformational analysis in the gas phase and in aqueous solution of regioisomeric melatonin analogs. A theoretical and experimental study H Mendoza-Figueroa, G Martínez-Gudiño, JE Villanueva-Luna, ... Journal of Molecular Structure 1133, 534-545, 2017 | 4 | 2017 |
| “Eco‐Friendly” Epimerization of Lutein to 3′‐Epilutein Under Solvent‐Free Mechanochemical Conditions by Using a Strongly Acidic Cation‐Exchange Resin AC Sánchez‐Chávez, HL Mendoza‐Figueroa, S Oliveros‐Cruz, ... European Journal of Organic Chemistry 2018 (24), 3202-3210, 2018 | 3 | 2018 |
| Apoptotic Effects of N-(2-hydroxyphenyl)-2-propylpentanamide on U87-MG and U-2 OS Cells and Antiangiogenic Properties P Castillo-Juárez, SC Sanchez, AD Chávez-Blanco, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2021 | 2 | 2021 |
| Melatonin pharmacophoric motifs in the anancomeric spiranic oxindole-cycloalkane scaffold: Theoretical and 1H NMR conformational analysis MS Morales-Ríos, DE González-Juárez, G Martínez-Gudiño, ... Journal of Molecular Structure 1202, 127267, 2020 | 1 | 2020 |
| GPER binding site detection and description: A flavonoid-based docking and molecular dynamics simulations study. D Méndez-Luna, S Guzmán-Velázquez, II Padilla-Martínez, ... The Journal of Steroid Biochemistry and Molecular Biology 239, 106474, 2024 | | 2024 |
| Untargeted LC-MS/MS Metabolomics Study of HO-AAVPA and VPA on Breast Cancer Cell Lines AR Estrada-Pérez, JB García-Vázquez, HL Mendoza-Figueroa, ... International Journal of Molecular Sciences 24 (19), 14543, 2023 | | 2023 |
| Avatares químicos. En busca de nuevos fármacos HLMFJCB Cynthia Fernández Pomares ¿cómo ves? Divulgación de la Ciencia, 8-12, 2023 | | 2023 |
| UHPLC-MS/MS Studies and Antiproliferative Effects in Breast Cancer Cells of Mexican Sargassum FVM Jonathan, D Darling, RHM Cecilia, EP Alan, MFH Lubriel, OC Ivonne, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2023 | | 2023 |
| REPURPOSING OF FDA-DRUGS AS POTENTIAL ERβ AGONISTS USING MULTICOMPLEX-BASED PHARMACOPHORE MAPS. A NEW APPROACH IN BREAST CANCER THERAPY LH Vazquez-Mendoza, J Garduño-Durán, J Correa-Basurto, ... XXXVIII Symposium of Bioinformatics and Computer-Aided Drug Discovery, 97-97, 2022 | | 2022 |
| Decrease in Cell Viability of Breast Cancer Cells by a Di-Hydroxylated Derivative of N-(2-hydroxyphenyl)-2-Propylpentanamide NL Galindo-Alvarez, HL Mendoza-Figueroa, MC Rosales-Hernández, ... Anti-cancer agents in medicinal chemistry, 2021 | | 2021 |
| Diseño y desarrollo de nuevos ligandos a receptores de melatonina MFH Lubriel https://repositorio.cinvestav.mx/handle/cinvestav/1298, 2017 | | 2017 |
| Síntesis y estudios de inducción asimétrica de alfa-cetoacetales macrocíclicos derivados del (1R)-(-)-mirtenal HL Mendoza Figueroa | | 2009 |
